Literature DB >> 27731453

KinView: a visual comparative sequence analysis tool for integrated kinome research.

Daniel Ian McSkimming1, Shima Dastgheib2, Timothy R Baffi3, Dominic P Byrne4, Samantha Ferries4, Steven Thomas Scott5, Alexandra C Newton3, Claire E Eyers4, Krzysztof J Kochut2, Patrick A Eyers4, Natarajan Kannan6.   

Abstract

Multiple sequence alignments (MSAs) are a fundamental analysis tool used throughout biology to investigate relationships between protein sequence, structure, function, evolutionary history, and patterns of disease-associated variants. However, their widespread application in systems biology research is currently hindered by the lack of user-friendly tools to simultaneously visualize, manipulate and query the information conceptualized in large sequence alignments, and the challenges in integrating MSAs with multiple orthogonal data such as cancer variants and post-translational modifications, which are often stored in heterogeneous data sources and formats. Here, we present the Multiple Sequence Alignment Ontology (MSAOnt), which represents a profile or consensus alignment in an ontological format. Subsets of the alignment are easily selected through the SPARQL Protocol and RDF Query Language for downstream statistical analysis or visualization. We have also created the Kinome Viewer (KinView), an interactive integrative visualization that places eukaryotic protein kinase cancer variants in the context of natural sequence variation and experimentally determined post-translational modifications, which play central roles in the regulation of cellular signaling pathways. Using KinView, we identified differential phosphorylation patterns between tyrosine and serine/threonine kinases in the activation segment, a major kinase regulatory region that is often mutated in proliferative diseases. We discuss cancer variants that disrupt phosphorylation sites in the activation segment, and show how KinView can be used as a comparative tool to identify differences and similarities in natural variation, cancer variants and post-translational modifications between kinase groups, families and subfamilies. Based on KinView comparisons, we identify and experimentally characterize a regulatory tyrosine (Y177PLK4) in the PLK4 C-terminal activation segment region termed the P+1 loop. To further demonstrate the application of KinView in hypothesis generation and testing, we formulate and validate a hypothesis explaining a novel predicted loss-of-function variant (D523NPKCβ) in the regulatory spine of PKCβ, a recently identified tumor suppressor kinase. KinView provides a novel, extensible interface for performing comparative analyses between subsets of kinases and for integrating multiple types of residue specific annotations in user friendly formats.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27731453      PMCID: PMC5508867          DOI: 10.1039/c6mb00466k

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  103 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Sequence and structure-based prediction of eukaryotic protein phosphorylation sites.

Authors:  N Blom; S Gammeltoft; S Brunak
Journal:  J Mol Biol       Date:  1999-12-17       Impact factor: 5.469

3.  A chaperone-dependent GSK3beta transitional intermediate mediates activation-loop autophosphorylation.

Authors:  Pamela A Lochhead; Ross Kinstrie; Gary Sibbet; Teeara Rawjee; Nick Morrice; Vaughn Cleghon
Journal:  Mol Cell       Date:  2006-11-17       Impact factor: 17.970

Review 4.  Active and inactive protein kinases: structural basis for regulation.

Authors:  L N Johnson; M E Noble; D J Owen
Journal:  Cell       Date:  1996-04-19       Impact factor: 41.582

5.  Evolutionary diagnosis method for variants in personal exomes.

Authors:  Sudhir Kumar; Maxwell Sanderford; Vanessa E Gray; Jieping Ye; Li Liu
Journal:  Nat Methods       Date:  2012-09       Impact factor: 28.547

6.  Interaction between Src and a C-terminal proline-rich motif of Akt is required for Akt activation.

Authors:  Tianyun Jiang; Yun Qiu
Journal:  J Biol Chem       Date:  2003-02-24       Impact factor: 5.157

Review 7.  Protein kinase C: poised to signal.

Authors:  Alexandra C Newton
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-24       Impact factor: 4.310

8.  Binding of STIL to Plk4 activates kinase activity to promote centriole assembly.

Authors:  Tyler C Moyer; Kevin M Clutario; Bramwell G Lambrus; Vikas Daggubati; Andrew J Holland
Journal:  J Cell Biol       Date:  2015-06-22       Impact factor: 10.539

9.  COSMIC: exploring the world's knowledge of somatic mutations in human cancer.

Authors:  Simon A Forbes; David Beare; Prasad Gunasekaran; Kenric Leung; Nidhi Bindal; Harry Boutselakis; Minjie Ding; Sally Bamford; Charlotte Cole; Sari Ward; Chai Yin Kok; Mingming Jia; Tisham De; Jon W Teague; Michael R Stratton; Ultan McDermott; Peter J Campbell
Journal:  Nucleic Acids Res       Date:  2014-10-29       Impact factor: 16.971

10.  Deciphering the structural basis of eukaryotic protein kinase regulation.

Authors:  Hiruy S Meharena; Philip Chang; Malik M Keshwani; Krishnadev Oruganty; Aishwarya K Nene; Natarajan Kannan; Susan S Taylor; Alexandr P Kornev
Journal:  PLoS Biol       Date:  2013-10-15       Impact factor: 8.029

View more
  20 in total

Review 1.  Protein kinase C as a tumor suppressor.

Authors:  Alexandra C Newton
Journal:  Semin Cancer Biol       Date:  2017-05-02       Impact factor: 15.707

2.  Protein kinase Cα gain-of-function variant in Alzheimer's disease displays enhanced catalysis by a mechanism that evades down-regulation.

Authors:  Julia A Callender; Yimin Yang; Gema Lordén; Natalie L Stephenson; Alexander C Jones; John Brognard; Alexandra C Newton
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-29       Impact factor: 11.205

Review 3.  Protein kinase C: perfectly balanced.

Authors:  Alexandra C Newton
Journal:  Crit Rev Biochem Mol Biol       Date:  2018-04       Impact factor: 8.250

4.  Protein Kinase C Quality Control by Phosphatase PHLPP1 Unveils Loss-of-Function Mechanism in Cancer.

Authors:  Timothy R Baffi; An-Angela N Van; Wei Zhao; Gordon B Mills; Alexandra C Newton
Journal:  Mol Cell       Date:  2019-03-20       Impact factor: 17.970

5.  Tracing the origin and evolution of pseudokinases across the tree of life.

Authors:  Annie Kwon; Steven Scott; Rahil Taujale; Wayland Yeung; Krys J Kochut; Patrick A Eyers; Natarajan Kannan
Journal:  Sci Signal       Date:  2019-04-23       Impact factor: 8.192

6.  Activation of atypical protein kinase C by sphingosine 1-phosphate revealed by an aPKC-specific activity reporter.

Authors:  Taketoshi Kajimoto; Alisha D Caliman; Irene S Tobias; Taro Okada; Caila A Pilo; An-Angela N Van; J Andrew McCammon; Shun-Ichi Nakamura; Alexandra C Newton
Journal:  Sci Signal       Date:  2019-01-01       Impact factor: 8.192

7.  A Chemical Probe for Dark Kinase STK17B Derives Its Potency and High Selectivity through a Unique P-Loop Conformation.

Authors:  Alfredo Picado; Apirat Chaikuad; Carrow I Wells; Safal Shrestha; William J Zuercher; Julie E Pickett; Frank E Kwarcinski; Parvathi Sinha; Chandi S de Silva; Reena Zutshi; Shubin Liu; Natarajan Kannan; Stefan Knapp; David H Drewry; Timothy M Willson
Journal:  J Med Chem       Date:  2020-11-20       Impact factor: 7.446

Review 8.  Reversing the Paradigm: Protein Kinase C as a Tumor Suppressor.

Authors:  Alexandra C Newton; John Brognard
Journal:  Trends Pharmacol Sci       Date:  2017-03-08       Impact factor: 14.819

9.  Covalent inhibitors of EGFR family protein kinases induce degradation of human Tribbles 2 (TRIB2) pseudokinase in cancer cells.

Authors:  Daniel M Foulkes; Dominic P Byrne; Wayland Yeung; Safal Shrestha; Fiona P Bailey; Samantha Ferries; Claire E Eyers; Karen Keeshan; Carrow Wells; David H Drewry; William J Zuercher; Natarajan Kannan; Patrick A Eyers
Journal:  Sci Signal       Date:  2018-09-25       Impact factor: 8.192

10.  mTORC2 controls the activity of PKC and Akt by phosphorylating a conserved TOR interaction motif.

Authors:  Timothy R Baffi; Gema Lordén; Jacob M Wozniak; Andreas Feichtner; Wayland Yeung; Alexandr P Kornev; Charles C King; Jason C Del Rio; Ameya J Limaye; Julius Bogomolovas; Christine M Gould; Ju Chen; Eileen J Kennedy; Natarajan Kannan; David J Gonzalez; Eduard Stefan; Susan S Taylor; Alexandra C Newton
Journal:  Sci Signal       Date:  2021-04-13       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.